According to the UALCAN dataset, RNF112 mRNA expression was downregulated in BLCA tissues with different lymph node metastasis statuses, tumor stages, and molecular subtypes compared with normal tissues (Figure 1B–D). This evidence concerns the gene RNF112 and bladder transitional cell carcinoma.